Patient characteristics |
N |
Overall |
Phosphatemia |
≤1.45 mmol/L
(n=190) |
>1.45 mmol/L
(n=216) |
P-value |
Male sex (%) |
406 |
61.0 |
64.7 |
57.4 |
0.131 |
Age, year (m ± SD) |
406 |
68.2 ± 14.8 |
72.3 ± 12.1 |
64.5 ± 16.1 |
<0.001 |
Mode of dialysis initiation (%) |
406 |
|
|
|
0.831 |
Hemodialysis |
|
86.7 |
86.3 |
87.0 |
|
Peritoneal dialysis |
|
13.3 |
13.7 |
13.0 |
|
Emergency first dialysis (%) |
406 |
36.0 |
38.4 |
33.8 |
0.333 |
Body mass index, kg/m2 (m ± SD) |
396 |
26.8 ± 5.5 |
26.0 ± 5.1 |
27.6 ± 5.7 |
0.003 |
Primary renal disease (%) |
405 |
|
|
|
0.008 |
Diabetic nephropathy |
|
23.0 |
19.0 |
26.4 |
|
Hypertensive nephropathy |
|
23.5 |
29.1 |
18.5 |
|
Glomerulonephritis |
|
10.3 |
6.9 |
13.4 |
|
Hereditary nephropathy |
|
5.4 |
7.4 |
3.7 |
|
Other/unknown |
|
37.8 |
37.6 |
38.0 |
|
Comorbid conditions (%) |
|
|
|
|
|
Cardiovascular disease |
406 |
60.1 |
64.7 |
56.0 |
0.073 |
Diabetes mellitus |
406 |
42.9 |
39.5 |
45.8 |
0.196 |
Respiratory disease |
406 |
14.8 |
15.8 |
13.9 |
0.590 |
Active malignancy |
406 |
4.7 |
5.8 |
3.7 |
0.321 |
At least 2 comorbidities |
406 |
47.3 |
51.6 |
43.5 |
0.105 |
Hypertension |
406 |
89.0 |
90.5 |
87.5 |
0.332 |
Biological parameters (m ± SD) |
|
|
|
|
|
Proteinuria, g/24h |
406 |
0.5 ± 0.5 |
0.5 ± 0.5 |
0.5 ± 0.5 |
0.652 |
Hemoglobin, g/L |
406 |
112.7 ± 13.7 |
114.1 ± 14.4 |
111.4 ± 12.9 |
0.048 |
Serum calcium, mmol/L |
401 |
2.2 ± 0.2 |
2.2 ± 0.2 |
2.1 ± 0.2 |
0.002 |
Parathyroid hormone, ng/L |
293 |
279.4 ± 270.5 |
237.0 ± 205.9 |
315.1 ± 311.0 |
0.014 |
Serum bicarbonate, mmol/L |
369 |
22.6 ± 3.7 |
22.9 ± 3.3 |
22.3 ± 3.9 |
0.119 |
Albuminemia, g/L |
320 |
35.2 ± 6.8 |
35.5 ± 6.7 |
34.8 ± 6.8 |
0.388 |
Total cholesterol, mmol/L |
324 |
3.6 ± 1.2 |
3.5 ± 0.9 |
3.7 ± 1.2 |
0.026 |
Triglycerides, mmol/L |
321 |
1.9 ± 1.1 |
1.8 ± 1.3 |
1.9 ± 1.0 |
0.561 |
Last GFR, mL/min/1.73m2 |
406 |
17.6 ± 8.2 |
18.2 ± 7.5 |
17.0 ± 8.7 |
0.148 |
M ± SD = Mean ± Standard Deviation, GFR = Glomerular Filtration Rate |
